Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Subhankar Metya
Institution:
Indian Institute of Technology Delhi
Observed institution:
Indian Institute of Technology Delhi
ORCID:
0000-0002-3395-6661
Observed ORCID:
0000-0002-3395-6661
OpenAlex ID:
A5093569508
Development of continuous processing platform utilizing aqueous two-phase extraction for purification of monoclonal antibodies
2023
·
Anupa Anupa
, Subhankar Metya
, et al.
·
Journal of Chromatography A
·
14
Challenges and developments in the manufacturing of high-concentration biotherapeutic monoclonal antibodies
2026
·
Anurag S. Rathore
, Subhankar Metya
, et al.
·
Advanced Drug Delivery Reviews
·
12
Continuous Processing for Manufacturing of Antibody–Drug Conjugates (ADCs)
2026
·
Subhankar Metya
, Pragya Prakash
, et al.
·
Bioconjugate Chemistry
·
4
Efficient and economical purification platform for production of therapeutic nanobodies
2025
·
Subhankar Metya
, Shoaib Haidar
, et al.
·
Protein Expression and Purification
·
4
Do We Really Need End‐To‐End Continuous Processing for Biomanufacturing of Monoclonal Antibodies?
2025
·
Anurag S. Rathore
, Subhankar Metya
, et al.
·
Biotechnology and Bioengineering
·
3
Recent developments in downstream processing of novel biotherapeutic modalities
2026
·
Anurag S. Rathore
, Subhankar Metya
, et al.
·
Trends in biotechnology
Show more works
View as search
Works count:
6
Citation count:
37
H-index:
4
I10-index:
2
Year
Topic
Type